Communiqués Agilent Technologies, Inc.

Actions

A

US00846U1016

Equipement et technologie médicale avancés

Marché Fermé - Nyse 22:00:03 08/06/2026 Après clôture 02:00:00
132,69 USD -2,03 % Graphique intraday de Agilent Technologies, Inc. 132,50 -0,14 %

Communiqués

03/06 Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation BU
02/06 Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma BU
01/06 Agilent Technologies : and Sound Analytics Collaborate to Advance LC/MS Workflows for Drug Metabolism Research PU
29/05 Agilent Technologies : Showcases Integrated Mass Spectrometry and Chromatography Solutions at ASMS 2026 PU
28/05 Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory BU
27/05 Agilent: Fiscal Q2 Earnings Snapshot AQ
27/05 Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results BU
26/05 Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control BU
26/05 Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality BU
22/05 Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis BU
21/05 Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research AQ
21/05 Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed BU
20/05 Agilent Announces Cash Dividend of 25.5 Cents per Share BU
19/05 Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026 BU
14/05 Enablement For Validity Versus Enablement For Anticipation: Lessons From Agilent Technologies, Inc. v. Synthego Corp. AQ
11/05 Agilent to Participate in Jefferies Global Healthcare Conference BU
04/05 Agilent Names Michael Buckner as Chief Legal Officer BU
28/04 Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27 BU
15/04 Agilent Showcases Cancer Research Solutions at AACR 2026 BU
14/04 Agilent Technologies : Partners OmixAI to Expand AI-Driven Proteomics in South Korea PU
01/04 Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader BU
26/03 Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma BU
20/03 Agilent Debuts Future of the Automated Laboratory at Korea Lab 2026 AQ
19/03 Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026 BU
11/03 Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States BU
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇